Position in JAZZ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$182,381,758
+$114,852,533 QoQ
Shares Held
756,865
+111.9% QoQ
Ownership
1.17%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#21
of 640 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in JAZZ Over Time
Shares Held
Position Value (USD)
Derivatives in JAZZ
reported options exposure · as of Sep 30, 2025CallValue
$659,000
CallShares
5,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. JAZZ ranks #11 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in JAZZ
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $182,381,758 | 756,865 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $67,529,225 | 357,203 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $80,401,840 | 472,952 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $59,898,750 | 454,467 | Shares | Defined | 2025-11-13 | |
| 2025-09-30 | $659,000 | 5,000 | Call | Defined | 2025-11-13 | |
| 2025-06-30 | $41,516,371 | 391,221 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $51,771,789 | 417,010 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $40,743,313 | 330,843 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $18,242,049 | 163,738 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $14,172,568 | 132,789 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $19,797,046 | 164,400 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $21,272,481 | 172,947 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $18,911,571 | 146,103 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $19,801,106 | 159,725 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $25,417,080 | 173,697 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $38,993,191 | 244,763 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $21,381,846 | 160,416 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $24,006,193 | 153,876 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $26,319,748 | 169,074 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $114,660 | 900 | Put | Defined | 2022-02-14 | |
| 2021-12-31 | $23,345,667 | 183,247 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $24,291,195 | 186,554 | Shares | Defined | 2021-11-15 | |
| 2021-09-30 | $117,189 | 900 | Put | Defined | 2021-11-15 | |
| 2021-06-30 | $31,522,572 | 177,452 | Shares | Defined | 2021-08-13 | |
| 2021-06-30 | $2,682,364 | 15,100 | Put | Defined | 2021-08-13 | |
| 2021-03-31 | $2,481,987 | 15,100 | Put | Defined | 2021-05-12 | |
| 2021-03-31 | $21,696,674 | 131,999 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $27,715,854 | 167,924 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $33,961,942 | 238,179 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $27,577,826 | 249,935 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $29,085,678 | 291,615 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||